Co-diagnostics, inc. (CODX) 2025Q4 financial report shows revenue of 263.92K USD, with a YoY growth rate of 76.74%. This outstanding figure clearly proves the company’s exceptionally strong operational momentum and significant expansion in market demand. To accurately capture Co-diagnostics, inc. (CODX)’s future growth potential, investors should closely follow subsequent financial reports and key strategic movements, and deeply integrate diversified data and tools such as Growin AI Value Analysis for a comprehensive and forward-looking strategic assessment.